The price-to-earnings ratio for DaVita Inc (NYSE: DVA) is above average at 13.97x, Company’s 36-month beta value is 1.11.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 8 as “hold,” and 0 as “sell.”
The public float for DVA is 71.82M, and currently, short sellers hold a 8.64% ratio of that floaft. The average trading volume of DVA on June 27, 2025 was 826.20K shares.
DVA) stock’s latest price update
DaVita Inc (NYSE: DVA) has seen a rise in its stock price by 0.52 in relation to its previous close of 140.36. However, the company has experienced a 3.90% gain in its stock price over the last five trading sessions. zacks.com reported 2025-06-16 that DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
DVA’s Market Performance
DVA’s stock has risen by 3.90% in the past week, with a monthly rise of 0.86% and a quarterly drop of -6.79%. The volatility ratio for the week is 2.22% while the volatility levels for the last 30 days are 2.06% for DaVita Inc The simple moving average for the last 20 days is 2.62% for DVA stock, with a simple moving average of -7.59% for the last 200 days.
Analysts’ Opinion of DVA
Many brokerage firms have already submitted their reports for DVA stocks, with Barclays repeating the rating for DVA by listing it as a “Equal Weight.” The predicted price for DVA in the upcoming period, according to Barclays is $133 based on the research report published on March 06, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see DVA reach a price target of $142, previously predicting the price at $100. The rating they have provided for DVA stocks is “Buy” according to the report published on August 07th, 2023.
Deutsche Bank gave a rating of “Hold” to DVA, setting the target price at $72 in the report published on November 01st of the previous year.
DVA Trading at 0.97% from the 50-Day Moving Average
After a stumble in the market that brought DVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.44% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DVA starting from BERKSHIRE HATHAWAY INC, who sale 103,274 shares at the price of $139.45 back on May 27 ’25. After this action, BERKSHIRE HATHAWAY INC now owns 33,796,541 shares of DaVita Inc, valued at $14,401,483 using the latest closing price.
BERKSHIRE HATHAWAY INC, the 10% Owner of DaVita Inc, sale 64,066 shares at $137.81 during a trade that took place back on May 23 ’25, which means that BERKSHIRE HATHAWAY INC is holding 33,899,815 shares at $8,828,933 based on the most recent closing price.
Stock Fundamentals for DVA
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.32 for the gross margin
The net margin for DaVita Inc stands at 0.07. The total capital return value is set at 0.14. Equity return is now at value 260.92, with 4.98 for asset returns.
Based on DaVita Inc (DVA), the company’s capital structure generated 1.02 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at -46.13. The interest coverage ratio of the stock is 4.04.
Currently, EBITDA for the company is 2.72 billion with net debt to EBITDA at 4.46. When we switch over and look at the enterprise to sales, we see a ratio of 1.74. The receivables turnover for the company is 4.7for trailing twelve months and the total asset turnover is 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.
Conclusion
In a nutshell, DaVita Inc (DVA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
